Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Pediatr. 2021 Jan 20;232:65–72.e7. doi: 10.1016/j.jpeds.2021.01.031

Table 4:

GEE model estimates for Severe AKI ~ treatment arm

AKI groups OR (95% CI)
Early AKI
NO vs 1/2/3 0.93 (0.62, 1.41)
NO or 1 vs 2/3 0.79 (0.32, 1.95)
Middle AKI
NO vs 1/2/3 0.99 (0.69, 1.44)
NO or 1 vs 2/3 0.67 (0.38, 1.20)
Late AKI
NO vs 1/2/3 1.04 (0.76, 1.42)
NO or 1 vs 2/3 0.86 (0.58, 1.25)
Anytime AKI
NO vs 1/2/3 1.11 (0.83, 1.48)
NO or 1 vs 2/3 0.76 (0.54, 1.07)

GEE models accouting for GA, sex, site and sibship clustering.

Estimates shown only for treatment arm - Epo vs Placebo